Search - tctmd.com

Displaying 101 - 120 of 943

Sort: Relevancy | Date

News Conference News ESC 2024

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

Yael L. Maxwell

September 04, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Daily News

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Caitlin E. Cox

August 28, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

Todd Neale

July 22, 2024

News Conference News SCCT 2024

Incidental CAC Tied to Worse Outcomes in Systemic Inflammatory Diseases

Todd Neale

July 21, 2024

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Caitlin E. Cox

July 10, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

News Daily News

AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps

Caitlin E. Cox

July 01, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

Todd Neale

June 24, 2024

Advertisement

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

September 2024 Dispatch for the CV Team

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

August 2024 Dispatch for the CV Team

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

Incidental CAC Tied to Worse Outcomes in Systemic Inflammatory Diseases

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps

July 2024 Dispatch for the CV Team

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Aspirin for Primary Prevention of CVD Remains Common in US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content